Singapore's TalkMed Group gets privatisation offer for $447 mln valuation (updated)

TalkMed

23/12/2024 24:02

(Updates with details from paragraph 2 onwards)
       Dec 23 (Reuters) - Singapore's oncology service provider
TalkMed Group  TALK.SI  said on Monday it had received a
privatisation offer from TW Troy, valuing the company at S$606.1
million ($447.24 million).
    TW Troy, indirectly owned by oncology-focused group Tamarind
Health, is offering TalkMed shareholders S$0.456 per share,
representing a premium of nearly 5% to the stock's last close on
Friday.
    The combined entity may consider a future listing on the
Singapore Exchange, TalkMed Group said.
    The deal also includes an investment by Temasek-backed 65
Equity Partners, resulting in an 18.3% stake in Tamarind Health.
    
($1 = 1.3552 Singapore dollars)

 (Reporting by Sneha Kumar in Bengaluru; Editing by Subhranshu
Sahu)
 ((Sneha.Kumar@thomsonreuters.com;))